GlaxoSmithKline Consumer Nigeria Plc

NGSE:GLAXOSMITH Stock Report

Market Cap: ₦20.3b

GlaxoSmithKline Consumer Nigeria Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Olakunle Oyelana

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure5.1yrs
CEO ownershipn/a
Management average tenure5.1yrs
Board average tenureno data

Recent management updates

Recent updates

CEO

Olakunle Oyelana

5.1yrs

Tenure

Mr. Olakunle Oyelana serves as Managing Director at GlaxoSmithKline Consumer Nigeria Plc. and serves as its Director. He had been General Manager at GlaxoSmithKline Consumer Nigeria Plc since August 2019....

Leadership Team

NamePositionTenureCompensationOwnership
Olakunle Oyelana
MD & Director5.1yrsno datano data
Peter Ogo
Head of Finance4.1yrsno datano data
Sherifat Akinwonmi
Head of Technologyno datano datano data
Oluchi Ononiwu
Ethics & Compliance Managerno datano datano data
Omongiade Ehighebolo
Director of Communication & Government Affairs6.3yrsno datano data
Soji Awotiwon
Head of Salesno datano datano data
Sherhyar Rao
Head of Marketing4.1yrsno datano data
Mark Pfister
Executive Directorno datano datano data
Uwemedimo Udoma
Head of Regulatory Affairsno datano datano data
Bosco Kirugi
Finance Director & Directorno datano datano data
Oluwafemi Olaogun
Head of Procurement5.1yrsno datano data
Olukunle Adewusi
Head of Corporate Reportingno datano datano data

5.1yrs

Average Tenure

Experienced Management: GLAXOSMITH's management team is seasoned and experienced (5.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/02/09 23:43
End of Day Share Price 2024/02/09 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GlaxoSmithKline Consumer Nigeria Plc is covered by 4 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Omotayo OyegunleCSL Stockbrokers Ltd
null nullFSDH Merchant Bank Limited
null nullMeristem Securities Limited